Theranos Founder Doc 'You Can See Everything' Surprises With $15M Opening

The documentary 'You Can See Everything' pulled in a surprise $15 million at the domestic box office this weekend, despite opening in fewer than 1,000 theaters. The film follows Elizabeth Holmes, the founder of Theranos, in the days before she reported to federal prison.

That number is a rare outlier for non-fiction cinema. Most documentaries struggle to reach even $1 million in wide release, and a $15 million opening from a limited footprint puts 'You Can See Everything' in the same conversation as major studio releases. The performance is a direct signal that audiences will pay to watch a real-world founder story unfold, especially one with the dramatic arc of Theranos.

For context, Theranos was once a Silicon Valley darling, with Holmes hailed as a visionary founder. The company's promise of revolutionary blood testing unraveled after investigative reporting raised questions about its technology. Holmes was later convicted on fraud charges, and the documentary captures the period just before she reported to prison.

The box office result is especially notable given the film's release strategy. Opening in fewer than 1,000 theaters is typically a sign of a niche title, not a commercial juggernaut. The high demand suggests that the Theranos story has moved beyond business news into mainstream culture, joining the ranks of true-crime business sagas that capture public attention for years.

For executives and boards, the documentary's success is a reminder that public perception is a durable asset - and a durable risk. Holmes built her company on a narrative of innovation and transparency; that same narrative became the basis for her downfall. The film's title, 'You Can See Everything,' cuts both ways: it evokes the transparency Holmes promised and the visibility that came with her public persona.

The financial implications for the documentary industry are significant. A $15 million opening from a limited release could shift how distributors think about non-fiction films. Instead of defaulting to streaming, they may see theatrical windows as a way to generate both revenue and cultural buzz. For investors in media companies, this is a signal that true-crime and business documentaries have a viable theatrical model.

The bigger lesson for founders is about legacy. Holmes' story is now being told and retold, and each retelling shapes how the next generation of entrepreneurs thinks about accountability. The documentary's box office performance proves that the market for these stories is not just strong - it is growing. For anyone running a company, the takeaway is simple: the narrative you build today will be the one that defines you tomorrow.